Drugs / Hematopoietic stem cells from bone marrow or peripheral blood
Hematopoietic stem cells from bone marrow or peripheral blood
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00606723 | Apr 2010 → Feb 2021 | acute myeloid leukemia | Hannover Medical School | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hematopoietic stem cells from bone marrow or peripheral blood | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00606723 ↗ |
| Route | Intravenous | “Suspension of stem cells is administered via intravenous infusion.” NCT00606723 ↗ |